Literature DB >> 3348311

Noninvasive maternal stroke volume and cardiac output determinations by pulsed Doppler echocardiography.

W Lee1, R Rokey, D B Cotton.   

Abstract

Sixteen obstetric patients with pulmonary artery catheters were studied by two-dimensional and pulsed Doppler echocardiography to compare prospectively pulsed Doppler-and thermodilution-derived estimations of left ventricular stroke volume and cardiac output. Systolic aortic flow velocity waveforms were obtained by pulsed Doppler ultrasound from the apical five-chamber echocardiographic window. Aortic diameters were obtained by two-dimensional echocardiography from the left parasternal long axis view. The mean (+/- SEM) aortic diameter averaged 2.1 +/- 0.1 cm, with a mean calculated aortic valve area of 3.6 +/- 0.2 cm2. The mean aortic flow velocity integral was 21.8 +/- 0.8 cm. This information was used to calculate aortic stroke volume and cardiac output. Thermodilution- and Doppler-derived estimations for maternal stroke volume (r = 0.86) and cardiac output (r = 0.94) were significantly correlated when aortic diameter measurements based on a leading vessel edge method were used. Our findings verify the accuracy of an important noninvasive technique for quantitating maternal stroke volume and cardiac output by pulsed Doppler echocardiography. This methodology should provide an alternative approach to invasive monitoring in the study of normal and abnormal maternal circulatory hemodynamics.

Entities:  

Mesh:

Year:  1988        PMID: 3348311     DOI: 10.1016/0002-9378(88)90014-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Three dimensional colour Doppler echocardiography for the characterisation and quantification of cardiac flow events.

Authors:  T Irvine; X N Li; R Rusk; D Lennon; D J Sahn; A Kenny
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

2.  A validation study of electrical cardiometry in pregnant patients using transthoracic echocardiography as the reference standard.

Authors:  Erin Martin; Adanna Anyikam; Jerasimos Ballas; Kristen Buono; Kristin Mantell; Thao Huynh-Covey; Thomas Archer
Journal:  J Clin Monit Comput       Date:  2015-09-24       Impact factor: 2.502

3.  Accuracy and trending ability of finger plethysmographic cardiac output monitoring in late pregnancy.

Authors:  Paul Bonnin; Benjamin Constans; Alain Duhamel; Maéva Kyheng; Anne-Sophie Ducloy-Bouthors; Max Gonzalez Estevez; Benoit Tavernier; Alexandre Gaudet
Journal:  Can J Anaesth       Date:  2022-08-04       Impact factor: 6.713

4.  Agreement between preload reserve measured by impedance cardiography and echocardiography during pregnancy.

Authors:  Huan Liang; Åse Vårtun; Ganesh Acharya
Journal:  Arch Gynecol Obstet       Date:  2018-04-05       Impact factor: 2.344

Review 5.  Phenotype-Directed Management of Hypertension in Pregnancy.

Authors:  Kelsey McLaughlin; John W Snelgrove; Laura E Sienas; Thomas R Easterling; John C Kingdom; Catherine M Albright
Journal:  J Am Heart Assoc       Date:  2022-03-14       Impact factor: 6.106

6.  Comparison of multiple non-invasive methods of measuring cardiac output during pregnancy reveals marked heterogeneity in the magnitude of cardiac output change between women.

Authors:  John W Petersen; Jing Liu; Yueh-Yun Chi; Melissa Lingis; R Stan Williams; Alice Rhoton-Vlasak; Mark S Segal; Kirk P Conrad
Journal:  Physiol Rep       Date:  2017-04

7.  Cardiac output measurements via echocardiography versus thermodilution: A systematic review and meta-analysis.

Authors:  Yun Zhang; Yan Wang; Jing Shi; Zhiqiang Hua; Jinyu Xu
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

8.  Cardiac output measured by transthoracic echocardiography and Swan-Ganz catheter. A comparative study in mechanically ventilated patients with high positive end-expiratory pressure.

Authors:  José Gorrasi; Arturo Pazos; Lucia Florio; Carlos Américo; Natalia Lluberas; Gabriel Parma; Ricardo Lluberas
Journal:  Rev Bras Ter Intensiva       Date:  2019 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.